Cargando…

Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review

PURPOSE OF THE REVIEW: Patients with end-stage renal disease (ESRD) are at a high risk of bacterial infection. We reviewed publications on risk factors, prevention, and treatment paradigms, as well as outcomes associated with bacterial infection in end-stage kidney disease. We focused in particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Lata, Chris, Girard, Louis, Parkins, Michael, James, Matthew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857243/
https://www.ncbi.nlm.nih.gov/pubmed/27152201
http://dx.doi.org/10.1186/s40697-016-0115-8
_version_ 1782430616070914048
author Lata, Chris
Girard, Louis
Parkins, Michael
James, Matthew T.
author_facet Lata, Chris
Girard, Louis
Parkins, Michael
James, Matthew T.
author_sort Lata, Chris
collection PubMed
description PURPOSE OF THE REVIEW: Patients with end-stage renal disease (ESRD) are at a high risk of bacterial infection. We reviewed publications on risk factors, prevention, and treatment paradigms, as well as outcomes associated with bacterial infection in end-stage kidney disease. We focused in particular on studies conducted in Canada where rates of haemodialysis catheter use are high. SOURCES OF INFORMATION: We included original research articles in English text identified from MEDLINE using search terms ‘chronic kidney failure’, ‘renal dialysis’, or ‘chronic renal insufficiency’, and ‘bacterial infection’. We focused on articles with Canadian study populations and included comparisons to international standards and outcomes where possible. FINDINGS: Bacterial infections in this setting are most commonly due to Gram-positive skin flora, particularly Staphylococcus, with methicillin-resistant Staphylococcus aureus (MRSA) carrying a poorer prognosis. Interventions that may decrease mortality from sepsis include a collaborative care model that includes a nephrology team, an infectious disease specialist, and use of standardized care bundles that adhere to proven quality-of-care indicators. Decreased infectious mortality may be achieved by ensuring appropriate antibiotic selection and dosing as well as avoiding catheter salvage attempts. Reduction in bloodstream infection (BSI) incidence has been observed with the use of tPA catheter-locking solutions and the use of mupirocin or polysporin as a topical agent at the catheter exit site, as well as implementing standarized hygiene protocols during catheter use. LIMITATIONS: There has been a paucity of randomized controlled trials of prevention and treatment strategies for catheter-related BSIs in haemodialysis. Some past trials have been limited by lack of blinding and short duration of follow-up. Microbiological epidemiology, although well characterized, may vary by region and treatment centre. IMPLICATIONS: With the high prevalence of catheter use in Canadian haemodialysis units, further studies on long-term treatment and preventative strategies for BSI are warranted.
format Online
Article
Text
id pubmed-4857243
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48572432016-05-06 Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review Lata, Chris Girard, Louis Parkins, Michael James, Matthew T. Can J Kidney Health Dis Review PURPOSE OF THE REVIEW: Patients with end-stage renal disease (ESRD) are at a high risk of bacterial infection. We reviewed publications on risk factors, prevention, and treatment paradigms, as well as outcomes associated with bacterial infection in end-stage kidney disease. We focused in particular on studies conducted in Canada where rates of haemodialysis catheter use are high. SOURCES OF INFORMATION: We included original research articles in English text identified from MEDLINE using search terms ‘chronic kidney failure’, ‘renal dialysis’, or ‘chronic renal insufficiency’, and ‘bacterial infection’. We focused on articles with Canadian study populations and included comparisons to international standards and outcomes where possible. FINDINGS: Bacterial infections in this setting are most commonly due to Gram-positive skin flora, particularly Staphylococcus, with methicillin-resistant Staphylococcus aureus (MRSA) carrying a poorer prognosis. Interventions that may decrease mortality from sepsis include a collaborative care model that includes a nephrology team, an infectious disease specialist, and use of standardized care bundles that adhere to proven quality-of-care indicators. Decreased infectious mortality may be achieved by ensuring appropriate antibiotic selection and dosing as well as avoiding catheter salvage attempts. Reduction in bloodstream infection (BSI) incidence has been observed with the use of tPA catheter-locking solutions and the use of mupirocin or polysporin as a topical agent at the catheter exit site, as well as implementing standarized hygiene protocols during catheter use. LIMITATIONS: There has been a paucity of randomized controlled trials of prevention and treatment strategies for catheter-related BSIs in haemodialysis. Some past trials have been limited by lack of blinding and short duration of follow-up. Microbiological epidemiology, although well characterized, may vary by region and treatment centre. IMPLICATIONS: With the high prevalence of catheter use in Canadian haemodialysis units, further studies on long-term treatment and preventative strategies for BSI are warranted. BioMed Central 2016-05-05 /pmc/articles/PMC4857243/ /pubmed/27152201 http://dx.doi.org/10.1186/s40697-016-0115-8 Text en © Lata et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Lata, Chris
Girard, Louis
Parkins, Michael
James, Matthew T.
Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review
title Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review
title_full Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review
title_fullStr Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review
title_full_unstemmed Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review
title_short Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review
title_sort catheter-related bloodstream infection in end-stage kidney disease: a canadian narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857243/
https://www.ncbi.nlm.nih.gov/pubmed/27152201
http://dx.doi.org/10.1186/s40697-016-0115-8
work_keys_str_mv AT latachris catheterrelatedbloodstreaminfectioninendstagekidneydiseaseacanadiannarrativereview
AT girardlouis catheterrelatedbloodstreaminfectioninendstagekidneydiseaseacanadiannarrativereview
AT parkinsmichael catheterrelatedbloodstreaminfectioninendstagekidneydiseaseacanadiannarrativereview
AT jamesmatthewt catheterrelatedbloodstreaminfectioninendstagekidneydiseaseacanadiannarrativereview